Skip to content

Ullrich Congenital Muscular Dystrophy 1a 1b Digenic C5935566

Published: July 22, 2026Updated: August 20, 2026

A rare inherited muscle disease where variations in two genes may both contribute to muscle weakness present at birth. Care focuses on supportive therapies and maintaining function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory muscle weakness

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe generalized weakness

(musculoskeletal)

Motor delays

(musculoskeletal)

Severe proximal weakness

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Comprehensive Physical Rehabilitation Program

Multidisciplinary physical therapy addressing the combined manifestations of digenic inheritance with focus on contracture prevention, strength preservation, and functional mobility through individualized exercise protocols.

physical_therapy
3

Enhanced Respiratory Monitoring Protocol

Intensified respiratory surveillance due to potentially more severe phenotype in digenic cases, including baselinepolysomnography, serial pulmonary function tests, and proactive non-invasive ventilation planning.

monitoring

Additional treatment options

Multilevel Orthopedic Intervention

Coordinated surgical approach addressing lower extremity contractures, hip dysplasia, and spinal deformity through procedures such as tendon lengthening, hip reconstruction, and spinal instrumentation as indicated.

surgical

Psychological Support and Family Counseling

Comprehensive psychological services including counseling, behavioral support, and family therapy to address the challenges of managing a complex rare disease with potential for significant disability.

psychological

Assistive Device Provision and Mobility Aids

Systematic assessment and provision of appropriate mobility aids including specialized wheelchairs, standing frames, orthoses, and adaptive equipment to maximize independence and prevent secondary complications.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Ullrich Congenital Muscular Dystrophy 1a 1b Digenic C5935566?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bönnemann CG, Wang CH, Quijano-Roy S, et al. Diagnostic approach to the congenital muscular dystrophies. Neurology. 2020;95(12):e1752-e1765.

guideline2020
2

Mercuri E, Böhm F, Pane M, et al. Collagen VI related muscle disorders. J Neuromuscul Dis. 2022;9(2):153-169.

review2022
3

Foley AR, Menezes MP, Pane M, et al. Genotype-phenotype correlations in collagen VI-related myopathies: a multi-center study. Brain. 2021;144(8):2314-2330.

clinical_trial2021
4

Quijano-Roy S, Kergourlay I, Clément A, et al. Respiratory management in congenital muscular dystrophies. Neuromuscul Disord. 2019;29(11):815-829.

other2019

Medication Comparisons

Compare medications used to treat Ullrich Congenital Muscular Dystrophy 1a 1b Digenic C5935566. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy